Tolu Balsam

This article discusses recent clinical trials investigating the use of Tolu Balsam as part of combination therapies for different medical conditions. Tolu Balsam, a natural resin extracted from the Myroxylon balsamum tree, has been used in traditional medicine for centuries. These trials aim to explore its potential benefits when combined with other active substances in modern pharmaceutical formulations.

Table of Contents

What is Tolu Balsam?

Tolu Balsam, also known as Balsam of tolu, is a natural substance that is sometimes used in certain antibiotic formulations[1]. It is classified as a structurally diverse substance, which means it’s a complex mixture of natural compounds rather than a single chemical entity.

Medical Uses

While Tolu Balsam itself is not an antibiotic, it is sometimes included in antibiotic formulations. In the clinical trials data provided, Tolu Balsam is mentioned as part of a combination drug that includes the antibiotics sulfamethoxazole and trimethoprim[1]. This combination is used to treat various bacterial infections.

Combination with Other Drugs

Tolu Balsam is often found in combination with other active substances in medicinal products. In the provided information, it’s part of a formulation that includes:

  • Sulfamethoxazole: An antibiotic that fights bacteria in the body
  • Trimethoprim: Another antibiotic that works in combination with sulfamethoxazole
  • Bromhexine Hydrochloride: A medication used to help clear mucus from the airways

This combination is classified under the ATC code J01EE01, which refers to a group of antibacterial drugs[1].

Potential Benefits

While the specific benefits of Tolu Balsam in this formulation are not detailed in the provided information, natural balsams are often included in medicinal preparations for their potential soothing properties. In this case, it may contribute to the overall effectiveness of the antibiotic formulation, but more research would be needed to confirm its specific role.

Considerations and Precautions

As with any medication, there are important considerations when using products containing Tolu Balsam:

  • The maximum daily dose of the combination product mentioned is 1600 mg, with a maximum total dose of 4800 mg over a 3-day period[2].
  • This medication is typically taken orally[2].
  • As with all medications, it’s crucial to follow your doctor’s instructions regarding dosage and duration of treatment.
  • If you have any allergies or sensitivities, especially to natural products, inform your healthcare provider before taking any medication containing Tolu Balsam.

It’s important to note that while Tolu Balsam is mentioned in these antibiotic formulations, the primary active ingredients for treating bacterial infections are the antibiotics sulfamethoxazole and trimethoprim. Always consult with a healthcare professional for personalized advice about using any medication.

Aspect Trial 1 Trial 2
Condition studied Pyogenic vertebral osteomyelitis Relapsed/refractory diffuse large B cell lymphoma
Tolu Balsam combination With sulfamethoxazole and trimethoprim With sulfamethoxazole, trimethoprim, and bromhexine hydrochloride
Administration route Oral Oral
Trial phase Phase IV Phase II
Primary objective Compare early oral antibiotic treatment to prolonged IV treatment Determine efficacy of MB-CART2019.1 cells
Key inclusion criteria Diagnosed PVO, decreased CRP, max 7 days of IV antibiotics Confirmed DLBCL, failed at least two lines of therapy

Ongoing Clinical Trials on Tolu Balsam

  • Study on 7-Day vs. 14-Day Antibiotic Treatment for Kidney Infection in Transplant Patients Using Bromhexine Hydrochloride, Trimethoprim, and Fluoroquinolones

    Recruiting

    1 1 1 1
    France
  • Study on Early Oral Antibiotic Treatment for Vertebral Osteomyelitis Using Cefuroxime, Dicloxacillin, and Ceftriaxone for Adult Patients

    Recruiting

    1 1 1 1
    Investigated diseases:
    Denmark

Glossary

  • Pyogenic vertebral osteomyelitis (PVO): An infection of the bones of the spine, typically caused by bacteria.
  • Diffuse large B cell lymphoma (DLBCL): A type of blood cancer that affects white blood cells called B cells.
  • Relapsed/refractory: Refers to a condition that has returned after treatment (relapsed) or does not respond to treatment (refractory).
  • Intravenous (IV): A method of administering medication directly into a vein.
  • Antibiotic (AB): A type of medication used to treat bacterial infections.
  • Chimeric antigen receptor (CAR): A type of protein that has been engineered to give T cells the ability to target specific cells.
  • Cytokine release syndrome (CRS): A condition that can occur as a side effect of some cancer treatments, causing fever, nausea, and other symptoms.
  • Leukapheresis: A procedure to separate and collect white blood cells from the blood.
  • Biopsy: A medical procedure to remove a small sample of tissue for examination.
  • Creatinine clearance: A test that measures how well your kidneys are working by estimating how much blood the kidneys can filter in a minute.

References

  1. http://clinicaltrials.eu/trial/study-on-early-oral-antibiotic-treatment-for-vertebral-osteomyelitis-using-cefuroxime-dicloxacillin-and-ceftriaxone-for-adult-patients/
  2. http://clinicaltrials.eu/trial/study-on-the-safety-and-effectiveness-of-mb-cart2019-1-for-patients-with-relapsed-or-refractory-diffuse-large-b-cell-lymphoma/